Smart Trial Design for Your Atherosclerosis Study
Atherosclerosis, also known as arteriosclerosis or hardening of the arteries, occurs as a result of plaque buildup on the artery walls. The condition can lead to other cardiac diseases or potentially fatal events.
Although researchers have identified certain risk factors for atherosclerosis, the cause remains unknown. Goals of current research projects include investigation for causes of artery damage, causes of plaque development, and causes of plaque rupture leading to blood clots. As research has uncovered more about the pathophysiology of atherosclerosis, these new learnings have revealed further complexities within the nature of the disease.
For your atherosclerosis study, Worldwide Clinical Trials has the resources and manpower you need to reach beyond the parameters of a one-size-fits-all clinical trial to provide a more precise and nuanced approach.
Using smart trial design, identifying critical biomarkers, and applying appropriate inclusion/exclusion criteria, we can optimize protocols to render the most reliable and robust data, on time and within budget.